InflaRx (IFRX) Raw Materials (2023 - 2025)
InflaRx's (IFRX) quarterly Raw Materials came in at $92922.6 in Q2 2025, down 37.66% year-over-year from $149056.3 in Q2 2024, and up 5.93% quarter-over-quarter from $87717.8 in Q4 2024.
Analysis
InflaRx (IFRX) Raw Materials (2023 - 2025) Analysis & Trends
InflaRx has disclosed Raw Materials across 3 years of filings, most recently posting $92922.6 for Q2 2025.
- In Q2 2025, Raw Materials fell 37.66% year-over-year to $92922.6; the TTM figure through Jun 2025 stood at $92922.6 (down 37.66% YoY), while the FY2024 annual figure was $87717.8, down 80.75% from the prior year.
- Raw Materials came in at $92922.6 for Q2 2025 at InflaRx, up from $87717.8 in the prior quarter.
- In the past five years, Raw Materials ranged from a high of $455725.1 in Q4 2023 to a low of $87717.8 in Q4 2024.
- Average Raw Materials over 3 years is $196355.4, with a median of $120989.4 recorded in 2024.
- Year-over-year, Raw Materials tumbled 80.75% in 2024 and tumbled 37.66% in 2025.
- Over 3 years, Raw Materials stood at $455725.1 in 2023, then plunged by 80.75% to $87717.8 in 2024, then grew by 5.93% to $92922.6 in 2025.
- Per Business Quant data, the three most recent Raw Materials figures were $92922.6 in Q2 2025, $87717.8 in Q4 2024, and $149056.3 in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | InflaRx | 139.29 Mn | -44.96 Mn | 2.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 92,922.57 |
| Dec 31, 2024 | 87,717.79 |
| Jun 30, 2024 | 149,056.32 |
| Dec 31, 2023 | 455,725.11 |